6: e18904 10.7554/eLife.18904 [DOI] [PMC free article] [PubMed] [Google Scholar] 12.Penagarikano O, Lazaro M, Lu X, Gordon A, Don H et al
Other ongoing clinical or observational studies not expected to directly support regulatory submissions are not disclosed We maintain an intellectual property portfolio comprising over 465 granted patents and over 625 patent applications as of December 31, 2025, which includes patents and patent applications applicable to our products and product candidates with claims directed to composition of matter, process, formulation and/or methods-of-use for our products and product candidates, including a product-specific device and core TransCon technologies
Blood pressure lowering drugs
The material on this Website may be out of date, or on rare occasions incorrect and we make no commitment to ensure that such material is correct or up to date
Certain people are poor responders, and it is not always possible to predict who will, and who will not, respond appropriately, she added
Today, we already have a stable and mature global market network and a large number of loyal consumers